Meritage Portfolio Management Pfizer Inc Transaction History

Meritage Portfolio Management

$1.63 Billion
Q3 2024

A detailed history of Meritage Portfolio Management transactions in Pfizer Inc stock. As of the latest transaction made, Meritage Portfolio Management holds 30,288 shares of PFE stock, worth $776,887. This represents 0.05% of its overall portfolio holdings.

Number of Shares

30,288

Previous 30,230 0.19%

Holding current value

$776,887

Previous $846,000 3.66%

% of portfolio

0.05%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$27.7 - $31.39 $1,606 - $1,820	58 Added 0.19%	30,288 $877,000
Q2 2024 Aug 08, 2024	SELL	$25.26 - $29.6 $1,540 - $1,805	-61 Reduced 0.2%	30,230 $846,000
Q1 2024 Apr 29, 2024	SELL	$25.89 - $29.73 $854 - $981	-33 Reduced 0.11%	30,291 $841,000
Q4 2023 Feb 02, 2024	BUY	$26.13 - $33.94 $7,238 - $9,401	277 Added 0.92%	30,324 $873,000
Q3 2023 Oct 30, 2023	SELL	$32.09 - $37.51 $5.66 Million - $6.62 Million	-176,437 Reduced 85.45%	30,047 $997,000
Q2 2023 Jul 31, 2023	SELL	$36.12 - $41.79 $5.16 Million - $5.96 Million	-142,726 Reduced 40.87%	206,484 $7.57 Million
Q1 2023 Apr 25, 2023	BUY	$39.39 - $51.28 $4.19 Million - $5.46 Million	106,444 Added 43.85%	349,210 $14.2 Million
Q4 2022 Feb 01, 2023	SELL	$41.75 - $54.5 $444,595 - $580,370	-10,649 Reduced 4.2%	242,766 $12.4 Million
Q3 2022 Oct 25, 2022	SELL	$43.76 - $53.42 $214,730 - $262,131	-4,907 Reduced 1.9%	253,415 $11.1 Million
Q2 2022 Jul 25, 2022	SELL	$46.53 - $55.17 $2.85 Million - $3.37 Million	-61,160 Reduced 19.14%	258,322 $13.5 Million
Q1 2022 Apr 25, 2022	BUY	$45.75 - $56.69 $9.59 Million - $11.9 Million	209,698 Added 191.01%	319,482 $16.5 Million
Q4 2021 Jan 28, 2022	SELL	$41.32 - $61.25 $306,222 - $453,923	-7,411 Reduced 6.32%	109,784 $6.48 Million
Q3 2021 Oct 26, 2021	SELL	$39.25 - $50.42 $37,562 - $48,251	-957 Reduced 0.81%	117,195 $5.04 Million
Q2 2021 Jul 26, 2021	BUY	$35.91 - $40.68 $252,088 - $285,573	7,020 Added 6.32%	118,152 $4.63 Million
Q1 2021 Apr 27, 2021	BUY	$33.49 - $37.77 $522,678 - $589,476	15,607 Added 16.34%	111,132 $4.03 Million
Q4 2020 Feb 03, 2021	BUY	$33.47 - $42.56 $67,006 - $85,205	2,002 Added 2.14%	95,525 $3.52 Million
Q3 2020 Oct 26, 2020	BUY	$31.75 - $37.25 $401,193 - $470,691	12,636 Added 15.62%	93,523 $3.43 Million
Q2 2020 Jul 27, 2020	SELL	$30.12 - $36.54 $1.18 Million - $1.44 Million	-39,324 Reduced 32.71%	80,887 $2.65 Million
Q1 2020 Apr 27, 2020	SELL	$27.03 - $38.62 $34,192 - $48,854	-1,265 Reduced 1.04%	120,211 $3.92 Million
Q4 2019 Jan 27, 2020	SELL	$32.92 - $37.36 $11,225 - $12,739	-341 Reduced 0.28%	121,476 $4.76 Million
Q3 2019 Oct 25, 2019	SELL	$32.49 - $42.13 $328,019 - $425,344	-10,096 Reduced 7.65%	121,817 $4.38 Million
Q2 2019 Jul 30, 2019	BUY	$36.98 - $41.52 $438,952 - $492,842	11,870 Added 9.89%	131,913 $5.71 Million
Q1 2019 Apr 25, 2019	SELL	$37.5 - $41.2 $37,200 - $40,870	-992 Reduced 0.82%	120,043 $5.1 Million
Q4 2018 Jan 25, 2019	SELL	$38.47 - $43.86 $62,629 - $71,404	-1,628 Reduced 1.33%	121,035 $5.28 Million
Q3 2018 Oct 30, 2018	SELL	$34.47 - $41.81 $42,225 - $51,217	-1,225 Reduced 0.99%	122,663 $5.41 Million
Q2 2018 Jul 25, 2018	SELL	$32.98 - $35.16 $312,155 - $332,789	-9,465 Reduced 7.1%	123,888 $4.49 Million
Q1 2018 Apr 26, 2018	SELL	$31.91 - $37.02 $29,516 - $34,243	-925 Reduced 0.69%	133,353 $4.73 Million
Q4 2017 Jan 29, 2018	SELL	$33.26 - $35.29 $77,662 - $82,402	-2,335 Reduced 1.71%	134,278 $4.86 Million
Q3 2017 Oct 16, 2017	BUY	$31.0 - $34.15 $4.24 Million - $4.67 Million	136,613	136,613 $4.88 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meritage Portfolio Management, based on Form 13F filings with the SEC.

News

Stay updated on Meritage Portfolio Management with notifications on news.

Account

Meritage Portfolio Management Pfizer Inc Transaction History